Trial intelligence / Profile preview

PA21 in dialysis patients with hyperphosphataemia

NCT01464190Phase 3Completed

Sponsor
CSL Vifor
Start
Sep 2011
Primary completion
Oct 2012
Countries
15
01

Overview

A Phase 3 trial of iron sucrose in hyperphosphatemia, sponsored by CSL Vifor. Started Sep 2011; status: completed.

02

Drugs

iron sucrose
03

Conditions

hyperphosphatemia

Beyond the preview

Go deeper on NCT01464190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01464190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call